UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.429-434

2014

Volltextzugriff (PDF)

Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy

Cancer Immunology, Immunotherapy, 2005-10, Vol.54 (10), p.1018-1025

2005

Volltextzugriff (PDF)

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

Annals of oncology, 2000-02, Vol.11 (2), p.227-228

2000

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of 10-Propargyl-10-deazaaminopterin, a New Antifolate

Clinical cancer research, 2000-09, Vol.6 (9), p.3493-3498

2000

Volltextzugriff (PDF)

Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1346-1350

2000

Volltextzugriff (PDF)

Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer

Seminars in oncology, 1999-10, Vol.26 (5), p.24-26

1999

Volltextzugriff (PDF)

Strategies to eradicate minimal residual disease in small cell lung cancer : High-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination

Seminars in oncology, 1999-10, Vol.26 (5), p.55-61

1999

Volltextzugriff (PDF)

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

Cancer, 2000-03, Vol.88 (5), p.1045-1050

2000

Volltextzugriff (PDF)

Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

Journal of clinical oncology, 2005-06, Vol.23 (17), p.3923-3931

2005

Volltextzugriff (PDF)

The Relationship of Ovarian Steroids, Headache Activity and Menstrual Distress: A Pilot Study With Female Migraineurs

Headache, 1992-06, Vol.32 (6), p.292-297

1992

Volltextzugriff (PDF)

A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7561-7561

2007

Volltextzugriff (PDF)

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1103-1109

2004

Volltextzugriff (PDF)

Na+, K+-Adenosine Triphosphatase Regulation in Hypertrophied Vascular Smooth Muscle Cells

Hypertension (Dallas, Tex. 1979), 1992-08, Vol.20 (2), p.144-150

1992

Volltextzugriff (PDF)

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein : A phase II clinical trial

Cancer, 2005-05, Vol.103 (10), p.2128-2131

2005

Volltextzugriff (PDF)

Can we really treat patients older than age 70 with a chemotherapy doublet for non-small cell lung cancer (NSCLC)?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7546-7546

2011

Volltextzugriff (PDF)

Forced vital capacity (FVC) as a reproducible measure of pulmonary function (PF) in chemotherapy-pretreated patients with malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7028-7028

2011

Volltextzugriff (PDF)

Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin

Clinical cancer research, 2004-09, Vol.10 (18), p.6094-6100

2004

Volltextzugriff (PDF)

Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid or N-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin

Clinical cancer research, 2004-02, Vol.10 (3), p.916-923

2004

Volltextzugriff (PDF)

Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS139-TPS139

2011

Volltextzugriff (PDF)

An Overview of Chemotherapy for Mesothelioma

Hematology/oncology clinics of North America, 2005-12, Vol.19 (6), p.1117-1136

Krug, Lee M.

2005

Volltextzugriff (PDF)

Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7557-7557

2010

Volltextzugriff (PDF)

Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7070-7070

2011

Volltextzugriff (PDF)

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

Cancer, 2005-11, Vol.104 (10), p.2149-2155

2005

Volltextzugriff (PDF)

Vaccine therapy for small cell lung cancer

Seminars in oncology, 2004-02, Vol.31 (1 Suppl 1), p.112-116

Krug, Lee M

2004

Volltextzugriff (PDF)

Phase I study of obatoclax mesylate (GX15–070MS), a bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3504-3504

2009

Volltextzugriff (PDF)

1 – 25 von 903

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(761)
Mit Volltextzugriff
(745)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

Phase I and Pharmacokinetic Study of 10-Propargyl-10-deazaaminopterin, a New Antifolate

Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer

Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer

Strategies to eradicate minimal residual disease in small cell lung cancer : High-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

The Relationship of Ovarian Steroids, Headache Activity and Menstrual Distress: A Pilot Study With Female Migraineurs

A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM)

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Na+, K+-Adenosine Triphosphatase Regulation in Hypertrophied Vascular Smooth Muscle Cells

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein : A phase II clinical trial

Can we really treat patients older than age 70 with a chemotherapy doublet for non-small cell lung cancer (NSCLC)?

Forced vital capacity (FVC) as a reproducible measure of pulmonary function (PF) in chemotherapy-pretreated patients with malignant pleural mesothelioma (MPM)

Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin

Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid or N-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin

Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)

An Overview of Chemotherapy for Mesothelioma

Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

Vaccine therapy for small cell lung cancer

Phase I study of obatoclax mesylate (GX15–070MS), a bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors

Suchergebnisse filtern